ArticleBMJ open2025

Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study.

Mojtaba Jafari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.